🇺🇸 FDA
Patent

US 9186362

Methods involving aldose reductase inhibitors

granted A61KA61K31/4164A61K31/4166

Quick answer

US patent 9186362 (Methods involving aldose reductase inhibitors) held by The Board of Regents of the University of Texas System expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4164, A61K31/4166, A61K31/4188, A61K31/499